C - Chemistry – Metallurgy – 12 – Q
Patent
C - Chemistry, Metallurgy
12
Q
C12Q 1/68 (2006.01) A61K 31/40 (2006.01) A61K 31/4439 (2006.01) A61K 49/00 (2006.01)
Patent
CA 2464995
This invention relates to the use of the novel association between the 483 A>G single nucleotide polymorphism of the TCF1 gene and the clinical response to glycemic control agents, such as DPPIV inhibitors, in patients with disorders of glycemic control, especially diabetes and impaired glucose metabolism. This invention provides methods to classify patients for treatment and/or for optimization of clinical studies and to treat patients based on this association.
L'invention concerne l'utilisation d'une nouvelle association entre le polymorphisme nucléotide unique 483 A>G du gène TCF1 et la réponse clinique aux agents de contrôle glycémique, tels que des inhibiteurs DPPIV, chez des patients présentant des troubles du contrôle glycémique, notamment diabètes, et du métabolisme glucosique anormal. L'invention concerne des procédés permettant la classification des patients pour le traitement et/ou l'optimisation des études cliniques et le traitement des patients sur la base de cette association.
Hughes Thomas Edward
Lavedan Christian Nicolas
Polymeropoulos Mihael Hristos
Fetherstonhaugh & Co.
Novartis Ag
LandOfFree
Methods to treat diabetes and related conditions based on... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods to treat diabetes and related conditions based on..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods to treat diabetes and related conditions based on... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1931548